About the Heart Tumors Session
Heart tumors pose a rare but significant challenge within the realm of cancer research. These growths, whether benign or malignant, demand specialized attention due to their unique location and potential impact on cardiac function. Diagnosis often requires a combination of advanced imaging modalities and biopsy procedures, enabling clinicians to accurately assess the nature of the tumor. Understanding the genetic and molecular signatures of these tumors is paramount, driving efforts to identify biomarkers for early detection and prognosis. Additionally, researchers are exploring targeted therapeutic approaches to effectively manage heart tumors, striving for improved outcomes and quality of life for affected individuals. Collaboration between oncologists, cardiologists, and researchers is fundamental in advancing our understanding and treatment of these intricate conditions, underscoring the importance of interdisciplinary efforts in oncology.
Topics Covered in Heart Tumors
Pediatric Rhabdomyoma
Primary Cardiac Sarcomas
Pericardial Metastases
Echocardiography
Endomyocardial Biopsy
Embolic Complications
Related Scientific Sessions at CIOC 2027
Why Attend the Heart Tumors Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Heart Tumors work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Heart Tumors research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Heart Tumors track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Heart Tumors Conference 2027 — FAQs
What is the Heart Tumors track at CIOC 2027?
The Heart Tumors track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Heart Tumors. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Heart Tumors sessions?
Cancer researchers and clinicians, educators and students with an interest in Heart Tumors are all welcome — whether presenting or attending.
Can I present my research in the Heart Tumors track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Heart Tumors sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Heart Tumors track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.
